TG Therapeutics, Inc. (TGTX)

NASDAQ: TGTX · Real-Time Price · USD

37.88

-0.07 (-0.18%)

Jun 27, 2025, 10:47 AM - Market open

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Novel Treatments for B-cell Diseases	329.00M	Log In	Log In	Log In	Log In	Upgrade
Novel Treatments for B-cell Diseases Growth	40.80%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	329.00M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	40.80%	Log In	Log In	Log In	Log In	Upgrade